Cargando…
Association between antidepressant use and liver fibrosis in patients with type 2 diabetes: a population based study
BACKGROUND: The prevalence of liver fibrosis among diabetic patients is increasing rapidly. Our study aims at exploring the relationship between antidepressant use and liver fibrosis in diabetic patients. METHODS: We conducted this cross-sectional study through the cycle of National Health and Nutri...
Autores principales: | Shi, Lin, Jia, Fangyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007740/ https://www.ncbi.nlm.nih.gov/pubmed/36899407 http://dx.doi.org/10.1186/s13098-023-01016-x |
Ejemplares similares
-
Association between use of liraglutide and liver fibrosis in patients with type 2 diabetes
por: Tan, Yijiong, et al.
Publicado: (2022) -
Medications in type-2 diabetics and their association with liver fibrosis
por: Siddiqui, Mohamed Tausif, et al.
Publicado: (2020) -
Antidepressant Medication Use, Weight Gain, and Risk of Type 2 Diabetes: A population-based study
por: Kivimäki, Mika, et al.
Publicado: (2010) -
Association between weight change and risk of liver fibrosis in adults with type 2 diabetes
por: Ke, Pan, et al.
Publicado: (2023) -
Association between Depression, Antidepression Medications, and the Risk of Developing Type 2 Diabetes Mellitus: A Nationwide Population-Based Retrospective Cohort Study in Taiwan
por: Fang, Yi-Jen, et al.
Publicado: (2021)